findmyKOL
Clinical trialNCT02324751CompletedPhase 2Interventional

Vaccines Against Salmonella Typhi

SponsorUniversity of OxfordEnrollment112Enteric FeverTyphoid Fever
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Andrew J Pollard, FRCPCH, PhD

    Oxford Vaccine Group, The University of Oxford

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Centre for Clinical Vaccinology and Tropical Medicine

    Oxford, Oxfordshire, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
2 Dec 2017
Completion
27 Jun 2022
Last update posted
5 Jul 2022
Registered enrollment
112
Registry id
NCT02324751

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.